mesdopetam   Click here for help

GtoPdb Ligand ID: 10811

Synonyms: IRL790
Compound class: Synthetic organic
Comment: Mesdopetam (IRL790) is an experimental small molecule compound with psychomotor stabilizing properties. The primary target is the dopamine D3 receptor, a target implicated in the generation of levodopa-induced dyskinesia, a side-effect frequently occurring with long-term levodopa treatment in patients with Parkinson's disease.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 63.78
Molecular weight 275.1
XLogP 2.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCNCCOc1cc(F)cc(c1)S(=O)(=O)C
Isomeric SMILES CCCNCCOc1cc(F)cc(c1)S(=O)(=O)C
InChI InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3
InChI Key OSBPYFBXSLJHCR-UHFFFAOYSA-N
References
1. Becanovic K, Vittoria de Donno M, Sousa VC, Tedroff J, Svenningsson P. (2020)
Effects of a Novel Psychomotor Stabilizer, IRL790, on Biochemical Measures of Synaptic Markers and Neurotransmission.
J Pharmacol Exp Ther, 374 (1): 126-133. [PMID:32358047]
2. Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A et al.. (2020)
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
J Pharmacol Exp Ther, 374 (1): 113-125. [PMID:32358046]